GlassScriptPhysician profile
Tayler H Long
NPI 1699743401
$13,404.21
in general payments reported to CMS, 2019-2025
49 companies · $2,278 in 2025
The $2,278 reported for 2025 was more than what 88% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
See the full distribution for Critical Care Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,797 · 2020: $919 · 2021: $2,124 · 2022: $2,312 · 2023: $2,119 · 2024: $1,854 · 2025: $2,278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,152 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,151.78 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,276.44 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,485.61 | 2019-2025 | Breztri, Airsupra, Fasenra |
| Mallinckrodt Hospital Products INC. | $853.21 | 2020-2025 | Acthar |
| Mylan Specialty L.P. | $827.06 | 2019-2024 | Yupelri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $784.30 | 2019-2025 | Ofev, Jascayd |
| Merck Sharp & Dohme LLC | $697.63 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Insmed, INC. | $693.93 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $625.63 | 2019-2025 | |
| Grifols USA, LLC | $560.88 | 2019-2025 | Prolastin-C Liquid |
| Inari Medical, INC. | $478.86 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Regeneron Healthcare Solutions, INC. | $408.60 | 2019-2025 | Dupixent |
| Baxter Healthcare | $388.37 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Takeda Pharmaceuticals U.S.A., INC. | $378.70 | 2020-2025 | Glassia |
| Janssen Pharmaceuticals, INC | $304.33 | 2020-2024 | Xarelto |
| Advanced Respiratory, INC | $286.90 | 2019-2021 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $249.52 | 2019-2025 | Smartvest |
| Pulmonx Corporation | $208.44 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Ani Pharmaceuticals, INC. | $189.95 | 2022-2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $133.90 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $131.29 | 2019-2020 | |
| Viatris Specialty LLC | $130.96 | 2025 | Yupelri |
| Paratek Pharmaceuticals, INC. | $130.81 | 2021-2022 | |
| Pfizer INC. | $124.46 | 2019 | |
| Philips North America LLC | $107.38 | 2019-2024 | (Ak6) Vest Therapy |
| Amgen INC. | $102.08 | 2023-2025 | Tezspire, Tavneos |
| Abbvie INC. | $79.98 | 2023-2025 | |
| United Therapeutics Corporation | $78.27 | 2021-2025 | Tyvaso, Tyvaso |
| Novartis Pharmaceuticals Corporation | $75.99 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $60.25 | 2021-2022 | |
| Gilead Sciences, INC. | $57.54 | 2023 | |
| Ambu INC. | $44.93 | 2023 | |
| Mayne Pharma Commercial LLC | $43.30 | 2019 | |
| Shire North American Group INC | $40.37 | 2019 | |
| Edwards Lifesciences Corporation | $36.91 | 2022 | |
| Mallinckrodt Enterprises LLC | $33.63 | 2019 | |
| Boston Scientific Corporation | $30.85 | 2022 | |
| Genentech USA, INC. | $30.16 | 2022 | |
| Liquidia Technologies, INC. | $28.53 | 2025 | Yutrepia |
| Tactile Systems Technology INC | $26.66 | 2022 | |
| Nabriva Therapeutics, Plc | $25.31 | 2022 | |
| Allergan, INC. | $22.75 | 2019 | |
| Inspire Medical Systems, INC. | $19.38 | 2023 | Inspire |
| Ethicon INC. | $17.47 | 2025 | Monarch Platform |
| Chiesi USA, INC. | $16.36 | 2019 | |
| Breas Medical, INC. | $16.04 | 2025 | Vivo 45 Ls |
| 3b Medical, INC. | $15.85 | 2024 | Luna |
| Olympus America INC. | $15.04 | 2021 | |
| Lilly USA, LLC | $14.71 | 2025 | Zepbound |
| Circassia INC. | $14.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tayler Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.